HomeNDRA • NASDAQ
add
ENDRA Life Sciences Inc
Previous close
$4.61
Day range
$4.44 - $4.74
Year range
$2.90 - $22.58
Market cap
3.57M USD
Avg Volume
52.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.30M | -41.68% |
Net income | -1.23M | 45.01% |
Net profit margin | — | — |
Earnings per share | -1.71 | 98.78% |
EBITDA | -1.29M | 41.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.81M | -71.74% |
Total assets | 2.81M | -73.11% |
Total liabilities | 1.33M | -7.87% |
Total equity | 1.47M | — |
Shares outstanding | 752.76K | — |
Price to book | 2.35 | — |
Return on assets | -108.82% | — |
Return on capital | -148.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.23M | 45.01% |
Cash from operations | -1.11M | 46.54% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 857.42K | -88.32% |
Net change in cash | -256.30K | -104.87% |
Free cash flow | -632.13K | 59.43% |
About
Founded
2008
Headquarters
Website
Employees
21
